evitria is a leading global provider of antibody expression services, based in Zurich, Switzerland. We specialize in the CHO-based transient expression of antibodies and other proteins, including bispecific and fusion antibodies.
With a proven track record of more than 120,000 successful transfections and the expression and purification of over 23,000 antibodies and antibody-based molecules for clients around the world (as of 2022), we bring a wealth of experience and expertise to every project we undertake. Our clients range from academic laboratories and small biotech start-ups to global biopharmaceutical companies, and we are proud to serve them all with the same high level of dedication and quality.
Whether you need a reliable partner for complete antibody production or simply need to manage capacity bottlenecks for single projects, evitria is the partner you can trust. We are committed to delivering exceptional results and value to every client, and we look forward to the opportunity to work with you.